Company Active LTD

Company profile

Senti Tech Limited

UK company 11112954, incorporated on 15 December 2017.

Senti - Landing Page - Senti.care

Senti is a clinical services and technology company - meaning we both provide direct patient care and develop technology to improve care.

Company number
11112954
Incorporated
15 Dec 2017
Companies House status
Active

Company identity

Founded / incorporated
15 December 2017

Company number 11112954

Verify at Companies House
Legal name
SENT2943 LIMITED
Company type
LTD
Region
East of England
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Senti Tech Limited
CRN 11112954
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

1 event
15 Dec
2017

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2022
Funded years
2022, 2023
Age at first award
4 years

Projects

2023 Launchpad Lead participant

Supply-Works - Unlocking the power of network effects for supplier intelligence and visibility in the medical devices sector

1 Sep 2023 to 29 Feb 2024

Awarded
£97,821
Total cost £97,821

**Background**: SMEs are particularly vulnerable to supply chain disruption. Supplier management takes up considerable time and energy for the whole team and presents significant risks to business continuity and viability. SMEs face further challenges through a lack of leverage in supplier relationships (lower-valued orders), competing against larger, bett...

2023 Collaborative R&D Lead participant

Arthritect: Advancing Precision Medicine of Inflammatory Arthritides through inflammatory biomarker sensing technology

1 Aug 2023 to 31 May 2025

Awarded
£468,895
Total cost £669,850

**Background:** Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are debilitating conditions that affect 1-2% of people. Irreversible joint damage builds up the longer these conditions remain ineffectively managed or untreated. Over 1-in-3 people with these conditions have to stop work within two years of symptoms starting. Yet, it takes over 6 mon...

2022 Collaborative R&D Lead participant

Research and Development of Senti-AI: Tech-enabled precision & predictive respiratory medicine leveraging an innovative wearable medical device

1 Apr 2022 to 30 Jun 2023

Awarded
£277,659
Total cost £396,655

**Background**: Imagine what the world would be like for the 500 million people globally suffering with long-term respiratory illnesses, if their lungs could tell them exactly what was wrong, how their illness was progressing, and precisely what to do about it? Well, they can: the problem is we've been listening to what the lungs can tell us, for the past...

Product types

Collaborative R&D Launchpad